RxDoctor Payments Data

Alexander Volkmar, MD

Orthopaedic Surgery · Ankeny, IANPI 1598228728

Payments from drug & device makers

What this record shows

This record is dominated by grants: $10,000 of the $15,522 with a category attached, or 64.4%. Smith+Nephew accounts for 79.6% of it on its own, with 7 other manufacturers making up the rest.

$15,522in general payments, 2019–2025

Across 57 payments — averaging $272.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$12K
  • Stryker$2K
  • Johnson & Johnson$311
  • Total Joint Orthopedics, Inc.$248
  • Encore Medical, LP$208
  • Globus Medical$93
  • plus $68 from 2 others

What the payments were for

  • Grants$10,00064%
  • Travel & lodging$2,91619%
  • Food & beverage$2,60717%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew9$12,351
Stryker33$2,244
Johnson & Johnson4$311
Total Joint Orthopedics, Inc.6$248
Encore Medical, LP2$208
Globus Medical1$93
Kinex Medical Company LLC1$47
Vertex1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,522 in reported general payments places this provider in the 85th percentile of 219 orthopaedic surgery providers in Iowa.

See all orthopaedic surgery providers in Iowa

Medicare billing

Part B allowed, 2024
$12,698
Medicare patients
51
Services billed
63

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib16$418
Cefadroxil16$129
Oxycodone Hcl21$121
Tramadol Hcl15$38
Omeprazole13$35
Meloxicam11$32
Ondansetron Hcl12$21

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Ankeny

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →